カテゴリ： MarketLine, 企業調査, 日本

Astellas Pharma Inc.：企業の戦略・SWOT・財務分析

◆英語タイトル：Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4954
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：58
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Astellas Pharma Inc. (Astellas or ‘the company’) manufactures,markets, import and export of pharmaceuticals and related products. It manufactures prescription drugs in therapeutic areas of urology, oncology, immunology, nephrology, muscle diseases, ophthalmology and neuroscience. The company sells its products under the brand names such as Gaster, Geninax Gonax, Harnal/Omnic, Funguard, Prograf, Vesicare, Geninax and Eligard among others. Astellas operates research centers in Japan. The company has its presence across Japan, the Americas, Europe, Middle East, and Africa (EMEA), Asia and Oceania. Astellas is headquartered in Tokyo, Japan.

Scope

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Astellas Pharma Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Astellas Pharma Inc.: Company Overview
Astellas Pharma Inc.: Overview and Key Facts
Astellas Pharma Inc.: Overview
Astellas Pharma Inc.: Key Facts
Astellas Pharma Inc.: Key Employees
Astellas Pharma Inc.: Key Employee Biographies
Astellas Pharma Inc.: Major Products and Services
Astellas Pharma Inc.: Company History
Astellas Pharma Inc.: Management Statement
Astellas Pharma Inc.: Locations and Subsidiaries
Astellas Pharma Inc.: Key Competitors
Astellas Pharma Inc.: Company Analysis
Astellas Pharma Inc.: Business Description
Astellas Pharma Inc.: SWOT Analysis
Astellas Pharma Inc.: SWOT Overview
Astellas Pharma Inc.: Strengths
Astellas Pharma Inc.: Weaknesses
Astellas Pharma Inc.: Opportunities
Astellas Pharma Inc.: Threats
Astellas Pharma Inc.: Corporate Financial Deals Activity
Astellas Pharma Inc.: Financial Deals Overview
Astellas Pharma Inc.: Targets and Partners
Astellas Pharma Inc.: Top Deals 2016 – 2020YTD*
Astellas Pharma Inc.: Advisors
Astellas Pharma Inc.: Top Legal Advisors
Astellas Pharma Inc.: Top Financial Advisors
Astellas Pharma Inc.: Mergers and Acquisitions
Astellas Pharma Inc.: Partnership
Astellas Pharma Inc.: Divestments
Astellas Pharma Inc.: Recent Developments
Astellas Pharma Inc.: News and Events Summary
Astellas Pharma Inc.: Business Expansion
Astellas Pharma Inc.: Corporate Social Responsibility
Astellas Pharma Inc.: Financial Deals
Astellas Pharma Inc.: Financial Performance
Astellas Pharma Inc.: Grants
Astellas Pharma Inc.: Market Developments
Astellas Pharma Inc.: Regulatory and Legal Events
Astellas Pharma Inc.: Research & Development
Astellas Pharma Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Astellas Pharma Inc.: Key Facts
Table 2: Astellas Pharma Inc.: Key Employees
Table 3: Astellas Pharma Inc.: Company History
Table 4: Astellas Pharma Inc.: Locations and Subsidiaries
Table 5: Astellas Pharma Inc.: Key Competitors
Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Astellas Pharma Inc.: M&A Activity by Geography (TTM*)
Table 8: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Astellas Pharma Inc.: Targets and Partners
Table 11: Astellas Pharma Inc.: Top Deals 2016 - 2020YTD*
Table 12: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Astellas Pharma Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Astellas Pharma Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Astellas Pharma Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Astellas Pharma Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Astellas Pharma Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Astellas Pharma Inc.: Divestments by Geography (2016 - YTD*2020)
Table 20: Astellas Pharma Inc.: News and Events Summary
Table 21: Astellas Pharma Inc.: Business Expansion
Table 22: Astellas Pharma Inc.: Corporate Social Responsibility
Table 23: Astellas Pharma Inc.: Financial Deals
Table 24: Astellas Pharma Inc.: Financial Performance
Table 25: Astellas Pharma Inc.: Grants
Table 26: Astellas Pharma Inc.: Market Developments
Table 27: Astellas Pharma Inc.: Regulatory and Legal Events
Table 28: Astellas Pharma Inc.: Research & Development
Table 29: Astellas Pharma Inc.: Strategy and Operations

★海外企業調査レポート[Astellas Pharma Inc.：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The Bank Of East Asia, Limited
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Taiho Pharmaceutical Co Ltd：企業の戦略的SWOT分析
    Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Gindalbie Metals Ltd：企業の戦略・SWOT・財務情報
    Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report Summary Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Orchid Orthopedic Solutions LLC：医療機器：M&Aディール及び事業提携情報
    Summary Orchid Orthopedic Solutions LLC (Orchid Orthopedic) is a medical device manufacturing company that offers orthopedic and medical device contract design, and manufacturing outsourcing services. The company provides proprietary solutions such as implant bone in-growth coatings, medical device …
  • BPCE SA：企業のM&A・事業提携・投資動向
    BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Creganna Medical：企業の戦略的SWOT分析
    Creganna Medical - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Franz Haniel & Cie. GmbH：企業の戦略的SWOT分析
    Franz Haniel & Cie. GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • J.W. Ostendorf Gmbh & Co Kg
    J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Orchid Pharma Ltd (ORCHIDPHAR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Raymond Ltd (RAYMOND EQ)：企業の財務・戦略的SWOT分析
    Raymond Ltd (RAYMOND EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sykes Enterprises Inc (SYKE)
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Westwater Resources, Inc.：企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bone Therapeutics SA (BOTHE)：医療機器：M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Global Power Equipment Group Inc-エネルギー分野：企業M&A・提携分析
    Summary Global Power Equipment Group Inc (Global Power) is a power company that manufactures and distributes auxiliary equipment. The company offers products such as gas and steam turbine auxiliary products, control houses and generator enclosures. It provides repair and maintenance, modification an …
  • Oil States International, Inc.：企業の戦略・SWOT・財務情報
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nitto Denko Corp (6988)：製薬・医療：M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • Chariot Oil & Gas Ltd (CHAR)：企業の財務・戦略的SWOT分析
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Ube Industries Ltd (4208)：企業の財務・戦略的SWOT分析
    Ube Industries Ltd (4208) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dechra Pharmaceuticals Plc (DPH)：企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, soludox, methoxasol, cyclospray and octacillin, among others. …
  • Boehringer Ingelheim GmbH：企業の戦略・SWOT・財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆